Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.2500
-0.0452 (-15.31%)
At close: May 13, 2025, 4:00 PM
0.2473
-0.0027 (-1.08%)
Pre-market: May 14, 2025, 7:16 AM EDT

Adaptimmune Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
41.0591.14143.99108.03149.9556.88
Upgrade
Short-Term Investments
18.5160.472.9596.57219.63311.34
Upgrade
Cash & Short-Term Investments
59.56151.61146.94204.61369.58368.22
Upgrade
Cash Growth
-58.54%3.18%-28.18%-44.64%0.37%311.22%
Upgrade
Accounts Receivable
4.381.450.827.440.750.14
Upgrade
Other Receivables
-14.5346.130.6533.2620.95
Upgrade
Receivables
4.3815.9846.9238.0934.0121.09
Upgrade
Inventory
11.767.381.331.280.752.09
Upgrade
Prepaid Expenses
-10.039.959.479.046.31
Upgrade
Other Current Assets
27.293.172.411.932.080.44
Upgrade
Total Current Assets
103188.17207.55255.37415.46398.15
Upgrade
Property, Plant & Equipment
48.9451.2271.7171.5451.3746.66
Upgrade
Other Intangible Assets
3.813.880.330.4411.73
Upgrade
Other Long-Term Assets
2.332.73.031.571.724.6
Upgrade
Total Assets
158.07245.96282.62328.92469.55451.14
Upgrade
Accounts Payable
5.78.698.134.758.116.39
Upgrade
Accrued Expenses
24.8630.928.8529.0629.5827.03
Upgrade
Current Portion of Leases
4.634.715.382.732.322.77
Upgrade
Current Income Taxes Payable
--1.4---
Upgrade
Current Unearned Revenue
12.4412.328.9723.5222.22.83
Upgrade
Other Current Liabilities
3.447.930.054.440.330.05
Upgrade
Total Current Liabilities
51.0764.5372.7964.562.5439.07
Upgrade
Long-Term Debt
25.4150.24----
Upgrade
Long-Term Leases
18.6719.2619.8520.3523.1520.94
Upgrade
Long-Term Unearned Revenue
95.9895.82149.06160.89177.2249.26
Upgrade
Other Long-Term Liabilities
4.374.271.41.30.670.64
Upgrade
Total Liabilities
195.5234.11243.1247.04263.59109.92
Upgrade
Common Stock
2.12.091.871.41.341.33
Upgrade
Additional Paid-In Capital
1,1061,1061,065990.66959.61935.71
Upgrade
Retained Earnings
-1,142-1,094-1,023-909.3-743.85-585.76
Upgrade
Comprehensive Income & Other
-4.41-1.9-3.75-0.88-11.14-10.05
Upgrade
Shareholders' Equity
-37.4311.8539.5181.88205.96341.23
Upgrade
Total Liabilities & Equity
158.07245.96282.62328.92469.55451.14
Upgrade
Total Debt
48.7174.2125.2423.0825.4723.71
Upgrade
Net Cash (Debt)
10.8677.4121.7181.53344.11344.51
Upgrade
Net Cash Growth
-90.95%-36.41%-32.96%-47.25%-0.11%437.59%
Upgrade
Net Cash Per Share
0.040.310.611.132.212.42
Upgrade
Filing Date Shares Outstanding
265.05257.23246.83165.31156.73155.14
Upgrade
Total Common Shares Outstanding
257.85255.94227.17164.52156.26154.79
Upgrade
Working Capital
51.93123.64134.76190.87352.92359.08
Upgrade
Book Value Per Share
-0.150.050.170.501.322.20
Upgrade
Tangible Book Value
-41.247.9739.1881.44204.96339.5
Upgrade
Tangible Book Value Per Share
-0.160.030.170.491.312.19
Upgrade
Machinery
-39.9138.9734.9232.6530.52
Upgrade
Construction In Progress
-0.280.0528.735.4-
Upgrade
Leasehold Improvements
-43.0157.9428.4628.728.36
Upgrade
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q